Skip to content
ABOUT
AUTHOR GUIDELINES
AUTHORS/EDITORS
SUBSCRIPTIONS
CONTACT US
MY ACCOUNT
Facebook
X
LinkedIn
Instagram
Search
×
HOME
PSYCH. BULLETIN
LATEST ISSUE
BLACK BOOK OF DOSING & MONITORING
RATING SCALES
LICENSING INFORMATION
RESOURCES
PSYCHOTROPICS A-Z
PSYCHOPHARMACOLOGY 101
NEWS
The Psychopharmacology Algorithm Project at the Harvard South Shore Psychiatry Program Bipolar Depression Algorithm
1
x
$
0.00
David V. Sheehan, MD, MBA: Current Approaches to the Pharmacologic Treatment of Anxiety Disorders
1
x
$
30.00
Thomas L. Schwartz, MD: The Use of Tiagabine Augmentation for Treatment-Resistant Anxiety Disorders: A Case Series
1
x
$
30.00
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
1
x
$
30.00
Demographic and Clinical Characteristics of Antipsychotic Drug-Treated Older Adults with Bipolar Disorder from the Global Aging & Geriatric Experiments in Bipolar Disorder Database (GAGE –BD)
1
x
$
30.00
Utilización del nombre de los fármacos
1
x
$
0.00
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
1
x
$
30.00
Ethical Issues in Schizophrenia: Considerations for Treatment and Research
1
x
$
30.00
VOL 3 No. 3 Full Issue - March 2001
1
x
$
20.00
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
1
x
$
30.00
View Cart
Checkout
Home
antipsychotic
“Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations” has been added to your cart.
View cart
Sort by
Date
Sort by
Name
Sort by
Price
Sort by
Date
Sort by
Popularity
Show
20 Products
Show
20 Products
Show
40 Products
Show
60 Products
Clozapine Prolongs Cortical Silent Period in Patients with Treatment- Resistant Schizophrenia
$
30.00
Add to cart
Details
Asenapine Transdermal Patch for the Management of Schizophrenia
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 49 No. 2, 2019 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Identifying Predictors of Primary Adherence to Second Generation Long-Acting Injectable Antipsychotics Following Discharge from an Acute Inpatient Psychiatry Unit
$
30.00
Add to cart
Details
Psychopharmacology Bulletin VOL 48 No. 3, 2018 – Full Issue Stacked PDF
$
90.00
Add to cart
Details
Do Long-Acting Injectable Antipsychotics Prevent or Delay Hospital Readmission?
$
30.00
Add to cart
Details
Deanna L. Kelly, PharmD, BCPP: Ziprasidone and the QTc Interval: Pharmacokinetic and Pharmacodynamic Considerations
$
30.00
Add to cart
Details
Michael T. Compton, MD: Antipsychotic-Induced Hyperprolactinemia and Sexual Dysfunction
$
30.00
Add to cart
Details
Robert R. Conley, MD: Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Drug–Drug Interactions Associated with Second-Generation Antipsychotics: Considerations for Clinicians and Patients
$
30.00
Add to cart
Details
Antipsychotic Induced Symptomatic Hyperprolactinemia
$
30.00
Add to cart
Details
Paliperidone Double-blind, Placebo- and Active-Controlled, Study
$
30.00
Add to cart
Details
Agomelatine for Depression in Schizophrenia by Jochen Mutschler
$
30.00
Add to cart
Details
Page load link
Go to Top
